NanoLuc-Driven Multiplex Imaging Platforms Incorporating Novel G-series Coelenterazine Variants
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.5c00654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Genta Kamiya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering Science, Graduate School of Informatics and Engineering, The University of Electro-Communications, Chofu, Tokyo 182-8585, J…. Hauptthemen laut MEDLINE: Pyrazines, Imidazoles, Luciferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Bioluminescence (BL) is widely used as an optical readout in bioassays and molecular imaging applications. In this study, we present a systematic approach to develop an advanced multiplex imaging system using novel coelenterazine (CTZ) analogs, termed the "G-series." We synthesized a library of 20 CTZ analogs with diverse functional groups at the C-2 and C-8 positions of the imidazopyrazinone backbone and classified them into five categories. These analogs were characterized with respect to luciferase specificity, BL stability, emission spectra, kinetics, and computationally predicted binding modes. Most of the G-series CTZ analogs were found to be water-soluble and exhibited excellent specificity for NanoLuc from Oplophorus luciferase, while G1 alone showed high specificity for ALuc16 derived from a group of copepod luciferases, together with unique emission colors including blue, green, and orange. The applicability of the G-series CTZ analogs for multiplex imaging was further evaluated using single-chain BL probes and by in vivo imaging of xenografts in living mice. The results showed that substrate G6 facilitates specific BL signals (red emission) from the single-chain probe in response to estrogen antagonists. The mice xenografted with subcutaneous (s.c.) tumors expressing ALuc16 and NanoLuc were imaged with excellent signal-to-background ratios using G1 and G20, respectively. This study demonstrates that the G-series CTZ analogs constitute a versatile and tunable molecular imaging platform with superior optical properties for both in vitro and in vivo applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Engineering Science, Graduate School of Informatics and Engineering, The University of Electro-Communications, Chofu, Tokyo 182-8585, Japan.
- School of Life Science and Technology, Institute of Science Tokyo, B-62 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan.
- Molecular Imaging Program at Stanford, Bio-X Program, Stanford University School of Medicine, Palo Alto 94304, California, United States.
- Environmental Management Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba 305-8569, Japan.
ORCID-Profile: Tadaomi Furuta, Arutselvan Natarajan, Ramasamy Paulmurugan, Sung-Bae Kim
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
Zitieren
APA
Kamiya, G., Kitada, N., Furuta, T., Thangudu, S., Natarajan, A., Paulmurugan, R., Maki, S. A., & Kim, S. B. (2026). NanoLuc-Driven Multiplex Imaging Platforms Incorporating Novel G-series Coelenterazine Variants. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00654
Vancouver
Kamiya G, Kitada N, Furuta T, Thangudu S, Natarajan A, Paulmurugan R, et al. NanoLuc-Driven Multiplex Imaging Platforms Incorporating Novel G-series Coelenterazine Variants. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.5c00654
BibTeX
@article{Kamiya2026,
author = {Kamiya, Genta and Kitada, Nobuo and Furuta, Tadaomi and Thangudu, Suresh and Natarajan, Arutselvan and Paulmurugan, Ramasamy and Maki, Shojiro A and Kim, Sung-Bae},
title = {NanoLuc-Driven Multiplex Imaging Platforms Incorporating Novel G-series Coelenterazine Variants},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.5c00654}
}
EUVIMED